Drexel Morgan & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $264K | Hold |
750
| – | – | 0.04% | 57 |
|
|
2025
Q4 | $245K | Hold |
750
| – | – | 0.04% | 57 |
|
|
2025
Q3 | $212K | Hold |
750
| – | – | 0.03% | 55 |
|
|
2025
Q2 | $209K | Hold |
750
| – | – | 0.04% | 56 |
|
|
2025
Q1 | $234K | Buy |
+750
| New | +$221K | 0.05% | 52 |
|
|
2024
Q4 | – | Sell |
-750
| Closed | -$242K | – | 56 |
|
|
2024
Q3 | $242K | Hold |
750
| – | – | 0.04% | 53 |
|
|
2024
Q2 | $234K | Hold |
750
| – | – | 0.05% | 51 |
|
|
2024
Q1 | $213K | Hold |
750
| – | – | 0.04% | 49 |
|
|
2023
Q4 | $216K | Hold |
750
| – | – | 0.05% | 51 |
|
|
2023
Q3 | $202K | Buy |
+750
| New | +$187K | 0.05% | 46 |
|
|
2021
Q3 | – | Sell |
-1,270
| Closed | -$310K | – | 46 |
|
|
2021
Q2 | $310K | Sell |
1,270
-1,240
| -49% | -$305K | 0.09% | 63 |
|
|
2021
Q1 | $625K | Hold |
2,510
| – | – | 0.16% | 60 |
|
|
2020
Q4 | $577K | Hold |
2,510
| – | – | 0.16% | 61 |
|
|
2020
Q3 | $638K | Hold |
2,510
| – | – | 0.22% | 55 |
|
|
2020
Q2 | $592K | Hold |
2,510
| – | – | 0.22% | 53 |
|
|
2020
Q1 | $509K | Hold |
2,510
| – | – | 0.2% | 54 |
|
|
2019
Q4 | $605K | Hold |
2,510
| – | – | 0.45% | 48 |
|
|
2019
Q3 | $486K | Hold |
2,510
| – | – | 0.38% | 54 |
|
|
2019
Q2 | $462K | Hold |
2,510
| – | – | 0.36% | 56 |
|
|
2019
Q1 | $476K | Sell |
2,510
-150
| -6% | -$28.6K | 0.42% | 54 |
|
|
2018
Q4 | $518K | Hold |
2,660
| – | – | 0.52% | 47 |
|
|
2018
Q3 | $551K | Hold |
2,660
| – | – | 0.48% | 51 |
|
|
2018
Q2 | $491K | Hold |
2,660
| – | – | 0.49% | 54 |
|
|
2018
Q1 | $454K | Sell |
2,660
-602
| -18% | -$111K | 0.47% | 58 |
|
|
2017
Q4 | $567K | Hold |
3,262
| – | – | 0.55% | 51 |
|
|
2017
Q3 | $608K | Hold |
3,262
| – | – | 0.62% | 44 |
|
|
2017
Q2 | $562K | Hold |
3,262
| – | – | 0.58% | 47 |
|
|
2017
Q1 | $535K | Hold |
3,262
| – | – | 0.59% | 47 |
|
|
2016
Q4 | $477K | Hold |
3,262
| – | – | 0.57% | 50 |
|
|
2016
Q3 | $544K | Hold |
3,262
| – | – | 0.6% | 48 |
|
|
2016
Q2 | $496K | Hold |
3,262
| – | – | 0.56% | 54 |
|
|
2016
Q1 | $489K | Hold |
3,262
| – | – | 0.57% | 54 |
|
|
2015
Q4 | $530K | Hold |
3,262
| – | – | 0.59% | 54 |
|
|
2015
Q3 | $451K | Sell |
3,262
-345
| -10% | -$54.4K | 0.58% | 51 |
|
|
2015
Q2 | $554K | Sell |
3,607
-602
| -14% | -$96.4K | 0.66% | 46 |
|
|
2015
Q1 | $673K | Buy |
4,209
+319
| +8% | +$50.2K | 0.72% | 46 |
|
|
2014
Q4 | $619K | Hold |
3,890
| – | – | 0.7% | 44 |
|
|
2014
Q3 | $546K | Hold |
3,890
| – | – | 0.66% | 45 |
|
|
2014
Q2 | $460K | Buy |
+3,890
| New | +$450K | 0.56% | 53 |
|
Other funds holding AMGN
VCM
VPM
Drexel Morgan & Co's AMGN Position: Q1 2026 in Review
Drexel Morgan & Co held its Amgen (AMGN) position steady in Q1 2026 at 750 shares worth $264K. The position accounts for 0.04% of the portfolio, ranked #57.
Drexel Morgan & Co first reported a position in AMGN in Q2 2014 and has held it in 39 quarters since. The position peaked at $673K in Q1 2015. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Drexel Morgan & Co held 750 shares of Amgen worth $264K as of Q1 2026.
- Drexel Morgan & Co left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.04% of Drexel Morgan & Co's portfolio in Q1 2026, its #57 holding.
- Drexel Morgan & Co first reported a position in Amgen in Q2 2014 and has held it in 39 quarters since.
- Drexel Morgan & Co's Amgen position peaked at $673K in Q1 2015.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Drexel Morgan & Co's 13F filing for Q1 2026, filed 11 May 2026.